Apelin, a Circulating Biomarker in Cancer Evaluation: A Systematic Review

SIMPLE SUMMARY: Despite advances in science and technology for the care of patients with cancer, providing effective treatment remains challenging. The lack of sensitive markers for early diagnosis and monitoring of cancer progression leads to suboptimal outcomes and decreased survival. There is a n...

Descripción completa

Detalles Bibliográficos
Autores principales: Grinstead, Christina, Yoon, Saunjoo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9564299/
https://www.ncbi.nlm.nih.gov/pubmed/36230579
http://dx.doi.org/10.3390/cancers14194656

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9564299/
https://www.ncbi.nlm.nih.gov/pubmed/36230579
http://dx.doi.org/10.3390/cancers14194656

Ejemplares similares